Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men.
Ryunosuke NakagawaHiroaki IwamotoTomoyuki MakinoRenato NaitoSuguru KadomotoNorihito AkataniHiroshi YaegashiShohei KawaguchiTakahiro NoharaKazuyoshi ShigeharaKouji IzumiYoshifumi KadonoAtsushi TakamatsuKotaro YoshidaAtsushi MizokamiPublished in: Cancers (2022)
Three prognostic factors for OS were identified in patients with mHNPC, namely GP5 inclusion, BSI ≥ 1.5, and LDH ≥ 300. Using these three factors, we developed a new prognostic model for OS that can more objectively predict patient prognosis.